{
  "ptid_time": "057_S_4888_2016-08-10",
  "img_path": "/data/qiuhui/data/adni/images/057_S_4888/2016-08-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 41,228 mm³, 7.0% above the reference mean. With a Z-score of 0.17 (56.7th percentile), this represents normal volume ; hippocampal volume measures 4,859 mm³, 35.7% below the reference mean. With a Z-score of -3.48 (0.0th percentile), this represents profound atrophy; whole brain volume measures 1,127,510 mm³, 4.5% above the reference mean. With a Z-score of 0.58 (71.9th percentile), this represents normal volume ; entorhinal cortex volume measures 1,859 mm³, 54.7% below the reference mean. With a Z-score of -3.71 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 20,271 mm³, 7.6% above the reference mean. With a Z-score of 0.65 (74.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,862 mm³, 2.2% below the reference mean. With a Z-score of -0.20 (42.0th percentile), this represents normal volume . ",
  "text_data": "Age is 78.8 years. Gender is Male. Education: 12 years. MMSE: 21.0. MoCA: 21.0. Logical Memory: 0.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.12 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows profound atrophy in the hippocampus and entorhinal cortex (both at 0th percentile), which are key regions affected in Alzheimer's disease. Cognitive scores (MMSE 21, MoCA 21) are below normal, consistent with cognitive impairment, and the presence of two APOE4 alleles increases Alzheimer's risk. However, AV45 (amyloid PET) is normal, which is atypical for AD but may suggest a non-AD pathology or a false-negative result.  \n\n**Diagnosis:** **Dementia** (likely neurodegenerative, but amyloid-negative profile complicates AD diagnosis).  \n**Confidence:** **Medium** (due to conflicting imaging and biomarker data).",
  "timestamp": "2025-07-26T08:13:56.618627"
}